top of page

ANAVEX New Website - Untitled Page.png

Search

The Dual Regulation of Oxidative Stress by SIGMA1 Receptors in Physiological/Pathological Conditions

Mar 31, 2017

The 13th International Conference on Alzheimer’s and Parkinson’s Diseases, March 29 to April 2, 2017, in Vienna, Austria.

Nino Goguadze, Nino Natsvlishvili, Elene Zhuravliova, Didier Morin, Davit Mikeladze and Tangui Maurice

View Poster

Recent Posts

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

bottom of page